MX2023001536A - Nuevo compuesto de cicloalquenona o sal del mismo. - Google Patents
Nuevo compuesto de cicloalquenona o sal del mismo.Info
- Publication number
- MX2023001536A MX2023001536A MX2023001536A MX2023001536A MX2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A
- Authority
- MX
- Mexico
- Prior art keywords
- salt
- compound
- active ingredient
- therapeutic agent
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020135328 | 2020-08-07 | ||
| PCT/JP2021/029246 WO2022030606A1 (ja) | 2020-08-07 | 2021-08-06 | 新規なシクロアルケノン化合物又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023001536A true MX2023001536A (es) | 2023-03-08 |
Family
ID=80118163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023001536A MX2023001536A (es) | 2020-08-07 | 2021-08-06 | Nuevo compuesto de cicloalquenona o sal del mismo. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230295068A1 (https=) |
| EP (1) | EP4194435A4 (https=) |
| JP (1) | JP7109705B2 (https=) |
| KR (1) | KR20230043923A (https=) |
| CN (1) | CN116096361B (https=) |
| AU (1) | AU2021321705B2 (https=) |
| BR (1) | BR112023001832A2 (https=) |
| CA (1) | CA3188292A1 (https=) |
| MX (1) | MX2023001536A (https=) |
| TW (1) | TWI829001B (https=) |
| WO (1) | WO2022030606A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4477642A4 (en) * | 2022-02-09 | 2026-02-25 | Taiho Pharmaceutical Co Ltd | CRYSTALLINE FORM OF CYCLOHEXENONE COMPOUND |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6228893B1 (en) * | 1997-08-13 | 2001-05-08 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
| JP3836684B2 (ja) | 2001-02-19 | 2006-10-25 | 明治乳業株式会社 | 排尿障害治療剤 |
| WO2009111576A2 (en) | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
| CA2883879A1 (en) | 2012-09-07 | 2014-03-13 | Edison Pharmaceuticals, Inc. | Quinone derivatives for use in the modulation of redox status of individuals |
| WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| ES2849425T3 (es) | 2016-01-22 | 2021-08-18 | Taiho Pharmaceutical Co Ltd | Método de fabricación de alcohol de cadena larga de ciclohexenona de alta pureza |
| TWI831738B (zh) * | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物 |
-
2021
- 2021-08-06 KR KR1020237006213A patent/KR20230043923A/ko active Pending
- 2021-08-06 AU AU2021321705A patent/AU2021321705B2/en active Active
- 2021-08-06 WO PCT/JP2021/029246 patent/WO2022030606A1/ja not_active Ceased
- 2021-08-06 JP JP2022518890A patent/JP7109705B2/ja active Active
- 2021-08-06 US US18/040,862 patent/US20230295068A1/en active Pending
- 2021-08-06 TW TW110129168A patent/TWI829001B/zh active
- 2021-08-06 BR BR112023001832A patent/BR112023001832A2/pt unknown
- 2021-08-06 MX MX2023001536A patent/MX2023001536A/es unknown
- 2021-08-06 CA CA3188292A patent/CA3188292A1/en active Pending
- 2021-08-06 EP EP21853226.5A patent/EP4194435A4/en active Pending
- 2021-08-06 CN CN202180057124.1A patent/CN116096361B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3188292A1 (en) | 2022-02-10 |
| TW202216650A (zh) | 2022-05-01 |
| US20230295068A1 (en) | 2023-09-21 |
| JP7109705B2 (ja) | 2022-07-29 |
| TWI829001B (zh) | 2024-01-11 |
| BR112023001832A2 (pt) | 2023-02-23 |
| WO2022030606A1 (ja) | 2022-02-10 |
| KR20230043923A (ko) | 2023-03-31 |
| JPWO2022030606A1 (https=) | 2022-02-10 |
| CN116096361A (zh) | 2023-05-09 |
| EP4194435A1 (en) | 2023-06-14 |
| AU2021321705B2 (en) | 2024-02-29 |
| AU2021321705A1 (en) | 2023-03-09 |
| EP4194435A4 (en) | 2024-09-25 |
| CN116096361B (zh) | 2025-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022008344A2 (es) | Derivados de pirazolilo útiles como agentes anticancerígenos | |
| BR112023020442A2 (pt) | Inibidor da protease 1 específica de ubiquitina (usp1) | |
| CL2020003011A1 (es) | Compuesto de benzimidazol o sal del mismo, agente insecticida y acaricida para la agricultura y horticultura que contiene dicho compuesto, y método para usar el mismo | |
| PY2146661A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados a braf | |
| DOP2024000039A (es) | Derivados de quinolina como inhibidores de la integrina alfa4beta7 | |
| MX2022004451A (es) | Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1. | |
| MX2023006504A (es) | Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo. | |
| PE20220954A1 (es) | Compuesto de 2,6-dioxo-3,6-dihidropirimidina, bactericida agricola y horticola, nematicida y agente antifungico medico y veterinario | |
| DOP2012000128A (es) | Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa | |
| MX2018008671A (es) | Composicion para incrementar la expresion de pgc-1alfa. | |
| MX2024006251A (es) | Compuesto quimerico para la degradacion dirigida de la proteina del receptor de androgenos, metodo de preparacion y uso medico del mismo. | |
| ES3060711T3 (en) | 3-hydroxy-5-pregnane-20-one derivative and use thereof | |
| MX2024002696A (es) | Derivados del acido 2-amino-5,5-dimetilhexanoico como moduladores de sortilina para su uso en el tratamiento de enfermedades del sistema nervioso central. | |
| AR056369A1 (es) | Compuestos derivados de quinazolina y composicion farmaceutica | |
| MX2022003830A (es) | Compuesto de n-(1h-imidazol-2-il)benzamida y composicion farmaceutica que comprende el mismo como ingrediente activo. | |
| JOP20250057A1 (ar) | مركبات لعلاج السرطان | |
| CO2022008616A2 (es) | Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma | |
| ZA202403327B (en) | Halogenated phenylarsine oxide compound and application thereof | |
| MX2023001536A (es) | Nuevo compuesto de cicloalquenona o sal del mismo. | |
| MX2023011297A (es) | Antagonista del dominio de alfa/beta hidrolasa 6 (abhd6). | |
| AR109012A1 (es) | Sistema de administración transdérmica que contiene galantamina o sales de esta | |
| MX2021011007A (es) | Farmaco y método para tratar o prevenir las complicaciones de la diabetes mediante el uso del mismo farmaco. | |
| BR112021019779A2 (pt) | Novo composto e composição para prevenção ou tratamento de doenças respiratórias compreendendo os mesmos como ingrediente ativo | |
| ZA202400679B (en) | Dimethyl-substituted thiazololactam compound and use thereof | |
| AR060494A1 (es) | Compuestos antibacterianos |